High Throughput Screening -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2022
Global High Throughput Screening Market is expected to reach USD 21,911.2 million by 2022 supported by a CAGR of 8.0% during the forecast period of 2017 to 2022. The global high throughput screening market is mainly driven by the increasing adoption of innovative approaches in pharmaceutical and biotechnology companies, growing investment by private equity firms and venture capitalists, rising government funding for various R&D activities, increasing healthcare spending, and technological advancements. Further, growing research in toxicology and stem cell research provide significant opportunities in this market. However, high cost for HTS, intricacy in the field of assay development, and government regulations for drug development obstructs the growth of this market to some extent.
The global high throughput screening market is mainly segmented by product & service (Consumables & Reagents, Instruments, Software & Services), by technology (Cell based Assay, Ultra High Throughput Screening, Label Free Technology, Lab On A Chip), by application (Stem Cell Research, Toxicology Assessment, Primary Screening, Target Identification), by end user (Pharmaceuticals and Biotechnology Industry, Academics and Research Institutes, Contract Research Organizations, and others), and by geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).
Geographically, the global high throughput screening market is segmented into five major regions, namely North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. These regions are further analysed at a country level with the detailed qualitative and quantitative analysis. North America accounted for the major share in the global high throughput screening market in 2016, followed by Asia-Pacific, and Europe. The major share of the North American region is mainly attributed to the growing elderly population and increased Research and development expenditure in biopharmaceuticals and biotechnology industries. On the other hand, Asia-Pacific region is projected to grow at a fastest CAGR during the forecast period, due to increasing population, rising prevalence of various diseases, and growing R&D funding for the drug discovery and development.
The key players in the global high throughput screening market are MERCK KGaA, Charles River Laboratories International, Inc., AXXAM S.p.A., Thermo Fisher Scientific Inc., Danaher Corporation, Perkin Elmer, Agilent technologies, Bio-Rad Laboratories, Inc., Tecan Trading AG, Aurora Biomed, Inc, and Hamilton Company.
Scope of the Report
Market by Technology
Cell based assay
Ultra High Throughput Screening
Label Free Technology
Lab on A Chip
Market by Products & Services
Consumables & Reagents
Software & Services
Market by Application
Stem Cell Research
Market by End User
Pharmaceuticals and Biotechnology Industry
Academics and Research Institutes
Contract Research Organizations
Other End Users
Market by Geography:
Rest of Europe
Rest of Asia-Pacific
Rest of World
Key questions answered in the report-
Which are the high growth market segments in terms of technology, product & service, application, end user, and regions/countries?
What is the historical market for high throughput screening across the globe?
What are the market forecasts and estimates from the period 2015-2022?
What are the major drivers, challenges, opportunities and trends in the global high throughput screening market?
Who are the major players in the global high throughput screening market and what share of the market do they hold?
Who are the major players in various countries and what share of the market do they hold?
What are the competitive landscapes and who are the market leaders by sub-region in the global high throughput screening market?
What are the recent developments in the global high throughput screening market?
What are the different strategies adopted by the major players in the global high throughput screening market?
What are the geographical trends and high growth regions/ countries?
Who are the local emerging players in the global high throughput screening market and how do they compete with the global players?
Table of Content
1.1. Market Ecosystem
1.2. Currency and Limitations
1.3. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation
3. Executive Summary
4. Market Insights
4.2. Market Dynamics
18.104.22.168. Increasing Adoption of Innovative Approaches in Pharmaceutical and Biotechnology Companies
22.214.171.124. Increasing Investment by Private Equity Firms and Venture Capitalists
126.96.36.199. Rising Government Initiatives and Funding For R&D
188.8.131.52. Increasing Healthcare Spending
184.108.40.206. Technological Advancements
220.127.116.11. High Cost of HTS
18.104.22.168. Intricacy in the Field of Assay Development
22.214.171.124. Government Regulations For Drug Development
126.96.36.199. Growing Toxicology and Stem Cell Research
4.3. Key industry Trends
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here
Source: EIN Presswire